D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 151,356
- Value
- $1.50M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 151,356 | $1.50M | <0.1% | +124,187+457.1% | Added | Holders |
| Q1 2026 | 27,169 | $166.5K | <0.1% | −6,603−19.6% | Reduced | Holders |
| Q4 2025 | 33,772 | $280.6K | <0.1% | +33,772 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −59,771−100.0% | Sold out | Holders |
| Q2 2025 | 59,771 | $672.4K | <0.1% | +59,771 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −546,418−100.0% | Sold out | Holders |
| Q4 2024 | 546,418 | $5.37M | <0.1% | −326,233−37.4% | Reduced | Holders |
| Q3 2024 | 872,651 | $7.11M | <0.1% | +438,742+101.1% | AddedConverted for a 1-for-40 split | Holders |
| Q2 2024 | 17,356,369 | $5.80M | <0.1% | +17,271,215+20,282.3% | Added | Holders |
| Q1 2024 | 85,154 | $98.8K | <0.1% | −315,217−78.7% | Reduced | Holders |
| Q4 2023 | 400,371 | $676.6K | <0.1% | +389,594+3,615.1% | Added | Holders |
| Q3 2023 | 10,777 | $19.5K | <0.1% | +10,777 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −10,805−100.0% | Sold out | Holders |
| Q1 2023 | 10,805 | $14.4K | <0.1% | −15,600−59.1% | Reduced | Holders |
| Q4 2022 | 26,405 | $44.6K | <0.1% | +26,405 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −11,390−100.0% | Sold out | Holders |
| Q2 2022 | 11,390 | $27.0K | <0.1% | −2,200,370−99.5% | Reduced | Holders |
| Q1 2022 | 2,211,760 | $8.91M | <0.1% | +1,925,476+672.6% | Added | Holders |
| Q4 2021 | 286,284 | $2.38M | <0.1% | −607,904−68.0% | Reduced | Holders |
| Q3 2021 | 894,188 | $10.4M | <0.1% | +894,188 | New | Holders |